Venturi Wealth Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-1,024
Closed -$147K – 1541
2024
Q4
$147K Sell
1,024
-345
-25% -$49.5K 0.01% 630
2024
Q3
$204K Buy
1,369
+300
+28% +$43K 0.01% 446
2024
Q2
$135K Buy
1,069
+358
+50% +$56.1K 0.01% 462
2024
Q1
$131K Sell
711
-49
-6% -$9.33K 0.01% 392
2023
Q4
$137K Buy
760
+51
+7% +$7.94K 0.01% 381
2023
Q3
$113K Buy
709
+140
+25% +$22.9K 0.01% 390
2023
Q2
$80.5K Sell
569
-458
-45% -$73.4K 0.01% 391
2023
Q1
$173K Buy
+1,027
New +$183K 0.01% 342

Other funds holding RGEN

Venturi Wealth Management's RGEN Position: Q1 2025 in Review

Venturi Wealth Management sold out of Repligen (RGEN) in Q1 2025, closing a stake of 1,024 shares — an estimated $147K sold.

Venturi Wealth Management first reported a position in RGEN in Q1 2023 and held it in 8 quarters. The position peaked at $204K in Q3 2024. 442 funds tracked by Wall St. Rank hold RGEN as of Q1 2025.

  • Venturi Wealth Management reported no remaining Repligen position as of Q1 2025 after selling out during the quarter.
  • Venturi Wealth Management sold 1,024 Repligen shares in Q1 2025, an estimated $147K.
  • Venturi Wealth Management first reported a position in Repligen in Q1 2023 and held it in 8 quarters.
  • Venturi Wealth Management's Repligen position peaked at $204K in Q3 2024.
  • 442 funds tracked by Wall St. Rank held Repligen as of Q1 2025.

Based on Venturi Wealth Management's 13F filing for Q1 2025, filed 6 May 2025.